Evaluation and treatment of postmenopausal osteoporosis

被引:24
作者
Scheiber, LB [1 ]
Torregrosa, L [1 ]
机构
[1] Henry Ford Wyandotte Hosp, Henry Ford Hlth Syst, Wyandotte, MI USA
关键词
osteoporosis; postmenopausal women; evaluation; diagnostic testing;
D O I
10.1016/S0049-0172(98)80004-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To review the recent literature and develop a logical strategy with which to approach the diagnosis and treatment of osteoporosis, based on clinical evidence and accepted practices, Methods: Published reports from 1983 through 1997 obtained by MEDLINE search were reviewed and analyzed by both authors. Results: Osteoporosis is a widespread medical condition readily identifiable by current diagnostic modalities, including quantitative computed tomography, single and dual x-ray absorbtiometry, radio-absorbtiometry, and ultrasound. Properly implemented prevention and treatment strategies, such as calcium and vitamin D supplementation, exercises, hormone replacement therapy, alendronate, and calcitonin, may reduce the future fracture risk in many individuals. An algorithm is provided based on currently available clinical evidence for the evaluation and treatment of osteoporosis. Conclusions: Expanded use of currently available and emerging diagnostic and therapeutic modalities should lead to decreased fracture rates and a resultant increase in quality of life for patients with osteoporosis. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:245 / 261
页数:17
相关论文
共 79 条
[1]  
Alexandre Christian, 1995, Current Opinion in Rheumatology, V7, P240, DOI 10.1097/00002281-199505000-00015
[2]  
ALOIA JF, 1993, CLOUR ATLAS OSTEOPOR
[3]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[4]  
BONE HG, 1994, TXB RHEUMATOLOGY
[5]  
BOOHER DL, 1990, CLEV CLIN J MED, V57, P154
[6]   TILUDRONATE - DEVELOPMENT AS AN OSTEOPOROSIS THERAPY [J].
CHESNUT, CH .
BONE, 1995, 17 (05) :S517-S519
[7]   Hormone replacement therapy in postmenopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density [J].
Chesnut, CH ;
Bell, NH ;
Clark, GS ;
Drinkwater, BL ;
English, SC ;
Johnston, CC ;
Notelovitz, M ;
Rosen, C ;
Cain, DF ;
Flessland, KA ;
Mallinak, NJS .
AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) :29-37
[8]   BONE MASS AND EXERCISE [J].
CHESNUT, CH .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 :S34-S36
[10]  
COBEN RM, 1997, INT MED WORLD REPORT, V12, P16